# Jon Cohen

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/jon-cohen
Canonical HTML page: https://gethealthbrief.com/entity/jon-cohen

## Timeline

- **2026-09-30**: Expected Closing — Anticipated completion of the merger following regulatory reviews.
- **2026-03-17**: Acquisition Announcement — UHS announces definitive agreement to acquire Talkspace for $835 million.
- **2026-02-21**: Q4 2025 Earnings — Both companies report record performance and optimistic 2026 outlooks.
- **2025-12-31**: Payer Milestone — Talkspace surpasses 140 million covered lives through payer partnerships.
- **2025-01-15**: Talkspace Profitability — Talkspace achieves its first full quarter of adjusted EBITDA profitability.
- **2024-05-15**: B2B Pivot — Talkspace shifts focus primarily to enterprise and payer-covered lives.
- **2024-03-01**: Commercial Launch — Initial rollout of iDose TR begins in the U.S. market with targeted accounts.
- **2023-12-14**: iDose TR FDA Approval — Glaukos receives landmark approval for its travoprost intracameral implant.
- **2021-06-22**: Talkspace IPO — Talkspace goes public via a SPAC merger at a $1.4 billion valuation.

## Recent coverage (2 stories)

### UHS to Acquire Talkspace for $835M in Major Behavioral Health Pivot
2026-03-17 15:57:41 · Sentiment: Neutral · Impact: 7/10 · Sources: 2

Universal Health Services (UHS) has entered into a definitive agreement to acquire digital mental health provider Talkspace for $835 million. The deal integrates a massive inpatient hospital network with a leading telehealth platform to create a comprehensive hybrid care model.
Full story: https://gethealthbrief.com/story/uhs-talkspace-acquisition-behavioral-health

### Glaukos and Talkspace Cap 2025 with Record Growth in MedTech and Digital Health
2026-02-21 07:45:00 · Sentiment: Neutral · Impact: 5/10 · Sources: 5

Glaukos Corporation and Talkspace, Inc. reported strong Q4 2025 financial results, highlighting a successful transition toward high-margin, recurring revenue models. Glaukos saw significant gains from its iDose TR launch, while Talkspace solidified its position as a profitable, payer-led behavioral health leader.
Full story: https://gethealthbrief.com/story/glaukos-talkspace-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.